Intravascular imaging for acute coronary syndrome.

Qingyue Tan, Zhiqing Wang, Fan Yang, Sant Kumar, Fu Wang, Jiawen Li, Jigang Wu, Shengxian Tu

Abstract readReview

In one paragraph

Review in NPJ cardiovascular health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

From Echo to Coronary Angiography: Optimizing Ischemia Evaluation Through Multimodal Imaging.Medicina (Kaunas, Lithuania) · 2025
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qingyue Tan *Biomedical Instrument Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.

Zhiqing Wang *Department of Cardiology, Huadong Hospital, Fudan University, Shanghai, China.

Fan YangBiomedical Instrument Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.

Sant KumarCreighton University School of Medicine, Department of Cardiology, Phoenix, Arizona, USA.

Fu WangBiomedical Instrument Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.

Jiawen LiSchool of Electrical and Mechanical Engineering and Institute for Photonics and Advanced Sensing, University of Adelaide, Adelaide, SA, 5005, Australia.

Jigang WuBiophotonics Laboratory, University of Michigan-Shanghai Jiao Tong University Joint Institute, Shanghai Jiao Tong University, Shanghai, China.

Shengxian TuBiomedical Instrument Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China. sxtu@sjtu.edu.cn.

Funding

the National Natural Science Foundation of China 82327808

6 · The paper itself

Abstract

Intravascular imaging is crucial for managing acute coronary syndrome (ACS) by identifying atherothrombotic causes, detecting vulnerable plaques, and guiding percutaneous coronary interventions. Over the past decade, advances in imaging, post-processing, hybrid morphological and molecular techniques, artificial intelligence, and computational modelling have enhanced clinical applications. This review summarizes current intravascular imaging modalities, their utility in ACS patients, and future directions to facilitate their appropriate use in clinical practice.

Identifiers

PMID41776330

DOI10.1038/s44325-025-00052-y

PMCPMC12912369

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.